To hear about similar clinical trials, please enter your email below
Trial Title:
Application of Antiosteoporosis Therapy in Osteolysis
NCT ID:
NCT05617846
Condition:
Limb; Fusion
Complication
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
Anti-osteoporosis therapy
Description:
Bone healing, limb function, and complications of postoperative osteolysis in patients
with bone tumors of the extremities treated with anti-osteoporosis therapy.
Arm group label:
Intervention group
Summary:
To report the postoperative complications and limb function of patients with osteolysis
after surgery for bone tumors of the extremities who received anti-osteoporosis therapy
in Henan Cancer Hospital in the next 10 years.
Detailed description:
A total of 100 patients with osteolysis after surgery for bone tumors of the four
extremities who received anti-osteoporosis treatment in Henan Cancer Hospital in the next
10 years were reported. The basic information, treatment methods, postoperative
complications and limb function of these patients were collected.
Criteria for eligibility:
Study pop:
Patients receiving antiosteoporosis therapy for osteolysis after surgery for bone tumors
in the extremities
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
1. No age restriction, male or female.
2. A subtype of bone tumor (including benign, malignant, and metastatic cancer) was
confirmed in the pathology department of the research institution.
3. Received excision of bone tumor in research institution.
Exclusion Criteria:
Not applicable.
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Department of Bone and Soft Tissue ,Henan Cancer Hospital
Address:
City:
Zhengzhou
Country:
China
Contact:
Last name:
Tian Zhichao, Dr.
Phone:
+8618737187831
Email:
tianzhichhaoyy@163.com
Start date:
December 28, 2024
Completion date:
November 30, 2032
Lead sponsor:
Agency:
Henan Cancer Hospital
Agency class:
Other
Source:
Henan Cancer Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05617846
